Current Report Filing (8-k)
October 29 2015 - 5:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
October 29, 2015
Date of Report (Date of Earliest
Event Reported)
IntelGenx Technologies Corp.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
000-31187 |
870638336 |
(State or other jurisdiction of |
(Commission File |
(IRS Employer Identification |
incorporation) |
Number) |
No.) |
6425 Abrams, Ville St- Laurent, Quebec, Canada |
H4S 1X9 |
(Address of principal executive offices) |
(Zip Code) |
Registrant's telephone number, including area code: (514)
331-7440
Check the appropriate box below if the Form 8K fining is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule
425 under the Securities Act (17CFR230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17CFR 240.14a -12)
[ ] Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communication pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01 Other Events - News Release
IntelGenx to Report Third Quarter 2015 Financial Results on
November 3, 2015.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
INTELGENX TECHNOLOGIES CORP.
Dated: October 29, 2015 |
By: /s/ Andre Godin |
|
------------------- |
|
Andre Godin |
|
Vice President and Chief Financial Officer
|
IntelGenx to Report Third Quarter 2015 Financial
Results on November 3, 2015
Saint Laurent, Quebec October 29,
2015 - IntelGenx Technologies Corp. (TSXV: IGX)
(OTCQX: IGXT) ("IntelGenx"), a leading drug delivery company focused on the
development of innovative products based on its proprietary oral drug delivery
technologies, today announced that it will release its third quarter 2015
results for the period ended September 30, 2015, on November 3, 2015 at the
close of the financial markets.
An accompanying conference call will take
place the following day and will be hosted by Dr. Horst G. Zerbe, President and
Chief Executive Officer and Mr. Andre Godin, Executive Vice-President and Chief
Financial Officer, to discuss the results and provide a business update. Details
of the conference call and webcast are below:
Date: Wednesday, November 4, 2015
Time: 9:00 a.m. EST
Conference dial-in: 1-866-393-4306
Conference ID: 66937976
International dial-in: (734) 385-2616
Webcast Registration: Click Here
Following the live call, a replay will be
available on the Company's website, www.intelgenx.com, under "Investor Relations".
About IntelGenx:
IntelGenx is a drug delivery company
focused on the development of oral controlled-release products as well as novel
rapidly disintegrating delivery systems. IntelGenx uses its unique multiple
layer delivery system to provide zero-order release of active drugs in the
gastrointestinal tract. IntelGenx has also developed novel delivery technologies
for the rapid delivery of pharmaceutically active substances in the oral cavity
based on its experience with rapidly disintegrating films. IntelGenx'
development pipeline includes products for the treatment of indications such as
severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS
indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal
health products. More information is available about the company at www.intelgenx.com.
Each of the TSX Venture Exchange and
OTCQX has neither approved nor disapproved the contents of this press
release.
CONTACT:
Edward Miller, Director, Investor
Relations
IntelGenx Corp.
T: +1 514-331-7440 (ext. 217)
edward@intelgenx.com
IntelGenx Technologies (CE) (USOTC:IGXT)
Historical Stock Chart
From Aug 2024 to Sep 2024
IntelGenx Technologies (CE) (USOTC:IGXT)
Historical Stock Chart
From Sep 2023 to Sep 2024